Therapeutic admission INR (≥2.0) was associated with smaller acute infarct volumes compared to no prior warfarin (p=0.001) and subtherapeutic INR (3.5-fold greater volume for INR <2.0; CI 2.9-4.2).
Case-Control (n=186)
Effect estimate: 3.5-fold greater volume (INR <2.0 vs ≥2.0) (95% CI 2.9-4.2)
p-value: p=0.014
OBJECTIVE: The level of anticoagulation at the time of stroke onset may influence the size, composition, and dissolution rate of the occlusive clot. We explored the relation between admission international normalized ratio (INR) and acute infarct volume in patients with ischemic stroke. METHODS: We studied 93 consecutive patients with preadmission warfarin use who had INR measurement and diffusion-weighted imaging performed within 24 hours of stroke onset. Ninety-three etiologic stroke subtype-matched patients without prior warfarin use served as control patients. Linear regression analysis was used to test for independence of INR as a predictor of infarct volume. RESULTS: In patients with preadmission warfarin use, admission INR was inversely correlated with lesion volume on diffusion-weighted imaging (r = -0.38). This relation was retained after adjustment for potential covariates (p = 0.014). INR less than 2.0 was associated with 3.5-fold (95% confidence interval, 2.9-4.2) greater lesion volume on diffusion-weighted imaging as compared with INR of 2.0 or more. Patients who were on therapeutic INR (>or=2.0) had smaller infarcts compared with patients without preadmission warfarin use (p = 0.001). Admission INR was inversely correlated with acute perfusion defect (r = -0.33), chronic infarct volume (r = -0.42), National Institutes of Health Stroke Scale score at admission (r = -0.27), and modified Rankin score at discharge (r = -0.28). INTERPRETATION: These results suggest that preadmission warfarin use associated with therapeutic level of anticoagulation can offer a benefit in limiting the extent of ischemic injury in an event of acute stroke.
Ay et al. (Fri,) conducted a case-control in Ischemic stroke (n=186). Preadmission warfarin use vs. No prior warfarin use was evaluated on Acute infarct volume on diffusion-weighted imaging (3.5-fold greater volume (INR <2.0 vs ≥2.0), 95% CI 2.9-4.2, p=0.014). Therapeutic admission INR (≥2.0) was associated with smaller acute infarct volumes compared to no prior warfarin (p=0.001) and subtherapeutic INR (3.5-fold greater volume for INR <2.0; CI 2.9-4.2).